Jessica Baud

856 total citations
22 papers, 465 citations indexed

About

Jessica Baud is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Jessica Baud has authored 22 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Jessica Baud's work include Sarcoma Diagnosis and Treatment (12 papers), Cancer Genomics and Diagnostics (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Jessica Baud is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Cancer Genomics and Diagnostics (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Jessica Baud collaborates with scholars based in France, United Kingdom and United States. Jessica Baud's co-authors include Cathy Staedel, Fabien Darfeuille, Sandrine Chabas, Jean‐Michel Coindre, Tom Lesluyes, Gaëlle Pérot, François Le Loarer, Frédéric Chibon, Lucie Chambonnier and Sophie Le Guellec and has published in prestigious journals such as PLoS ONE, Hepatology and Oncogene.

In The Last Decade

Jessica Baud

21 papers receiving 458 citations

Peers

Jessica Baud
Jessica Baud
Citations per year, relative to Jessica Baud Jessica Baud (= 1×) peers Masuo Hanada

Countries citing papers authored by Jessica Baud

Since Specialization
Citations

This map shows the geographic impact of Jessica Baud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Baud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Baud more than expected).

Fields of papers citing papers by Jessica Baud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Baud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Baud. The network helps show where Jessica Baud may publish in the future.

Co-authorship network of co-authors of Jessica Baud

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Baud. A scholar is included among the top collaborators of Jessica Baud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Baud. Jessica Baud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michot, Audrey, Pauline Lagarde, Tom Lesluyes, et al.. (2023). Analysis of the Peritumoral Tissue Unveils Cellular Changes Associated with a High Risk of Recurrence. Cancers. 15(13). 3450–3450.
2.
Tauziède‐Espariat, Arnault, François Le Loarer, Jessica Baud, et al.. (2022). A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions. Acta Neuropathologica Communications. 10(1). 15–15. 5 indexed citations
3.
Tauziède‐Espariat, Arnault, Mathilde Duchesne, Jessica Baud, et al.. (2022). NTRK‐rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class. Histopathology. 82(4). 596–607. 13 indexed citations
4.
Perret, Raul, Matthias Tallegas, Valérie Velasco, et al.. (2022). Recurrent YAP1::MAML2 fusions in “nodular necrotizing” variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases. Modern Pathology. 35(10). 1398–1404. 19 indexed citations
5.
Pérot, Gaëlle, Sophie Le Guellec, Nelly Desplat, et al.. (2021). ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas. Cancers. 13(9). 2151–2151. 9 indexed citations
6.
Loarer, François Le, et al.. (2021). Advances in the classification of round cell sarcomas. Histopathology. 80(1). 33–53. 15 indexed citations
7.
Perret, Raul, Michael Michal, Richard Carr, et al.. (2021). Superficial CD34‐positive fibroblastic tumor and PRDM10‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases. Histopathology. 79(5). 810–825. 27 indexed citations
8.
Delespaul, Lucile, Tom Lesluyes, Sophie Le Guellec, et al.. (2020). Cell–cell fusion of mesenchymal cells with distinct differentiations triggers genomic and transcriptomic remodelling toward tumour aggressiveness. Scientific Reports. 10(1). 21634–21634. 15 indexed citations
9.
Bouvier, Corinne, François Le Loarer, Nicolas Macagno, et al.. (2020). Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype “Acral FibroChondroMyxoid Tumors”. Modern Pathology. 33(7). 1360–1368. 18 indexed citations
10.
Baud, Jessica, Gaëlle Pérot, Tom Lesluyes, et al.. (2020). Tetraploidization of Immortalized Myoblasts Induced by Cell Fusion Drives Myogenic Sarcoma Development with DMD Deletion. Cancers. 12(5). 1281–1281. 4 indexed citations
11.
Brulard, Céline, Tom Lesluyes, Vanessa Delcroix, et al.. (2019). RCBTB1 Deletion Is Associated with Metastatic Outcome and Contributes to Docetaxel Resistance in Nontranslocation-Related Pleomorphic Sarcomas. Cancers. 11(1). 81–81. 4 indexed citations
12.
Lesluyes, Tom, Jessica Baud, Gaëlle Pérot, et al.. (2019). Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas. Modern Pathology. 32(12). 1786–1794. 28 indexed citations
13.
Delespaul, Lucile, Tom Lesluyes, Pauline Lagarde, et al.. (2019). Fusion-mediated chromosomal instability promotes aneuploidy patterns that resemble human tumors. Oncogene. 38(33). 6083–6094. 30 indexed citations
14.
Loarer, François Le, Sophie Laffont, Tom Lesluyes, et al.. (2019). Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum. The American Journal of Surgical Pathology. 43(6). 747–754. 57 indexed citations
15.
Houzé, Pascal, et al.. (2018). High Dose of Pralidoxime Reverses Paraoxon-Induced Respiratory Toxicity in Mice. Türk anestezi ve reanimasyon dergisi. 46(2). 131–138. 7 indexed citations
16.
Ravaud, Alain, Carlos Gomez‐Roca, Marie-Quitterie Picat, et al.. (2017). Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study. European Journal of Cancer. 85. 39–48. 2 indexed citations
17.
Delespaul, Lucile, Tom Lesluyes, Gaëlle Pérot, et al.. (2016). Recurrent TRIO Fusion in Nontranslocation–Related Sarcomas. Clinical Cancer Research. 23(3). 857–867. 31 indexed citations
18.
Baud, Jessica, Abderrahim Lomri, Denis Graber, & Andréas Bikfalvi. (2015). The therapeutic response in Gorham’s syndrome to the beta-blocking agent propranolol is correlated to VEGF-A, but not to VEGF-C or FLT1 expression. BMC Research Notes. 8(1). 333–333. 12 indexed citations
19.
Baud, Jessica, Christine Varon, Sandrine Chabas, et al.. (2013). Helicobacter pylori Initiates a Mesenchymal Transition through ZEB1 in Gastric Epithelial Cells. PLoS ONE. 8(4). e60315–e60315. 56 indexed citations
20.
Grise, Florence, Sandra Sena, Aurélien Bidaud-Meynard, et al.. (2012). Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion. Hepatology. 55(6). 1766–1775. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026